Quality of life in Italian patients with Multiple endocrine neoplasia type 1 (MEN 1): results of an extensive survey

Table 4 Scores of HADS, IES-R, LOT-R and SF36 in MEN1 patients, stratified by age

	n	Age	HADS-A	HADS -D	LOT-R	IES-R	SF-36
	n	Age	HADS-A	HADS -D	LOT-R	IES-R	PF	RP	BP	GH	VT	SF	RE	MH
18–44 years	30
Mean		32.96	8.1^a	8.66	14.06	25.63	89.16 ^a	80^a	83.66 ^a	59.33	60.53	73.56	76.56	67.3
SD ±		7.19	2.09	1.80	3.78	18.60	17.26	30.37	20.46	17.86	20.10	23.04	36.33	17.49
45–59 years	33
Mean		51.78	9.63^a	8.66	14.42	31.09	81.84	63.63	63.72^a	50.06	57.96	63.51	69.36	65.57
SD ±		4.18	2.77	1.63	3.04	18.12	19.87	42.43	28.22	27.25	21.09	25.81	39.47	18.55
60–74 years	10
Mean		65.5	8.7	8.7	15.1	39.4	71.2^a	47.5^a	63.4^a	46.4	51.1	64.7	63.1	68.4
SD ±		3.02	2.40	1.41	3.31	20.89	26.89	46.32	27.22	17.21	16.25	26.09	39.91	12.85
75–90 years	3
Mean		77	6.66	9	16.66	18.33	48.33^a	8.33^a	41.66^a	44.33	38.33	66.33	66.66	72
SD ±		2	4.04	0	3.05	20.03	14.43	14.43	17.03	10.69	24.66	7.50	57.73	16

HADS Hospital Anxiety and Depression Scale, HADS-A scores for anxiety, HADS-D scores for depression, LOT-R Life Orientation Test-Revised, IES-R Impact of Event Scale-Revised, SF-36 Variables of Study 36-item Short-Form Health Survey, PF Physical functioning, RP Role limitations due to physical health problems, BP Bodily pain, GH General health perceptions, VT Vitality, SF Social functioning, RE Role limitations due to emotional problems, MH General mental health
^ap < 0.05

ISSN: 1750-1172